CA2285457A1 - Method for oral delivery of proteins - Google Patents

Method for oral delivery of proteins Download PDF

Info

Publication number
CA2285457A1
CA2285457A1 CA002285457A CA2285457A CA2285457A1 CA 2285457 A1 CA2285457 A1 CA 2285457A1 CA 002285457 A CA002285457 A CA 002285457A CA 2285457 A CA2285457 A CA 2285457A CA 2285457 A1 CA2285457 A1 CA 2285457A1
Authority
CA
Canada
Prior art keywords
composition
insulin
hydrogels
maa
hydrogel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002285457A
Other languages
English (en)
French (fr)
Inventor
Mariko Morishita
Tsuneji Nagai
Nicholas A. Peppas
Anthony M. Lowman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Purdue Research Foundation
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2285457A1 publication Critical patent/CA2285457A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
CA002285457A 1997-04-02 1998-04-02 Method for oral delivery of proteins Abandoned CA2285457A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US4228097P 1997-04-02 1997-04-02
US60/042,280 1997-04-02
US6136797P 1997-10-08 1997-10-08
US60/061,367 1997-10-08
PCT/US1998/006563 WO1998043615A1 (en) 1997-04-02 1998-04-02 Method for oral delivery of proteins

Publications (1)

Publication Number Publication Date
CA2285457A1 true CA2285457A1 (en) 1998-10-08

Family

ID=26719055

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002285457A Abandoned CA2285457A1 (en) 1997-04-02 1998-04-02 Method for oral delivery of proteins

Country Status (14)

Country Link
EP (1) EP0975328A1 (zh)
JP (1) JP2002512607A (zh)
KR (1) KR20010005952A (zh)
CN (1) CN1259045A (zh)
AU (1) AU727053B2 (zh)
BR (1) BR9808466A (zh)
CA (1) CA2285457A1 (zh)
IL (1) IL132176A0 (zh)
NO (1) NO994757L (zh)
NZ (1) NZ500075A (zh)
PL (1) PL335974A1 (zh)
TR (1) TR199903240T2 (zh)
WO (1) WO1998043615A1 (zh)
YU (1) YU49699A (zh)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
DE10040592A1 (de) * 2000-08-15 2002-03-07 Aventis Res & Tech Gmbh & Co Formulierung zur verbesserten Aufnahme von Wirkstoffen und deren Verwendung
US6878384B2 (en) 2001-03-13 2005-04-12 Microvention, Inc. Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use
DE60318938T2 (de) 2002-03-20 2009-01-22 Mannkind Corp., Valencia Inhalationsgerät
DK1786784T3 (da) 2004-08-20 2011-02-14 Mannkind Corp Katalyse af diketopiperazinsyntese
JP4990142B2 (ja) 2004-08-23 2012-08-01 マンカインド コーポレイション 薬物送達のためのジケトピペラジン塩、ジケトモルホリン塩、又はジケトジオキサン塩
US8110212B2 (en) 2005-04-07 2012-02-07 Drexel University Bioactive thermogelling polymer systems and methods of their use
AU2005334837B2 (en) 2005-07-29 2012-07-19 Stichting Groningen Centre For Drug Research PH-controlled pulsatile delivery system, methods for preparation and use thereof
MX2008001643A (es) * 2005-08-01 2008-04-07 Mannkind Corp Metodo para conservar la funcion de celulas productoras de insulina.
HUE028691T2 (en) 2005-09-14 2016-12-28 Mannkind Corp A method for formulating a drug based on increasing the affinity of crystalline microparticle surfaces towards active ingredients
AU2007216966C1 (en) 2006-02-22 2014-03-20 Mannkind Corporation A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
CA2655026C (en) 2006-06-15 2016-08-02 Microvention, Inc. Embolization device constructed from expansible polymer
JP5698537B2 (ja) 2007-12-21 2015-04-08 マイクロベンション インコーポレイテッド 生物医学的使用のためのハイドロゲルフィラメント
ES2655921T3 (es) 2008-06-13 2018-02-22 Mannkind Corporation Un inhalador de polvo seco y sistema para administración de fármacos
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
ES2904623T3 (es) 2008-06-20 2022-04-05 Mannkind Corp Aparato interactivo para establecer un perfil en tiempo real de esfuerzos de inhalación
TWI532497B (zh) 2008-08-11 2016-05-11 曼凱公司 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
EP2405963B1 (en) 2009-03-11 2013-11-06 MannKind Corporation Apparatus, system and method for measuring resistance of an inhaler
WO2010144789A2 (en) 2009-06-12 2010-12-16 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
HUP0900482A2 (en) 2009-08-03 2011-03-28 Cera Med Kft Pharmaceutical formulation for oral administration
JP2013505791A (ja) 2009-09-24 2013-02-21 マイクロベンション インコーポレイテッド 医学的使用のための注射用ヒドロゲル繊維
US9993252B2 (en) 2009-10-26 2018-06-12 Microvention, Inc. Embolization device constructed from expansile polymer
WO2011056889A1 (en) 2009-11-03 2011-05-12 Mannkind Corporation An apparatus and method for simulating inhalation efforts
KR20130117755A (ko) 2010-06-21 2013-10-28 맨카인드 코포레이션 건조 분말 약물 운반 시스템 및 방법
CN105667994B (zh) 2011-04-01 2018-04-06 曼金德公司 用于药物药盒的泡罩包装
WO2012145431A2 (en) 2011-04-18 2012-10-26 Microvention, Inc. Embolic devices
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
WO2013063160A1 (en) 2011-10-24 2013-05-02 Mannkind Corporation Methods and compositions for treating pain
US9011884B2 (en) 2012-04-18 2015-04-21 Microvention, Inc. Embolic devices
CN108057154B (zh) 2012-07-12 2021-04-16 曼金德公司 干粉药物输送系统和方法
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
JP6523247B2 (ja) 2013-03-15 2019-05-29 マンカインド コーポレイション 微結晶性ジケトピペラジン粒子の製造方法および乾燥粉末組成物の製造方法
EP3021834A1 (en) 2013-07-18 2016-05-25 MannKind Corporation Heat-stable dry powder pharmaceutical compositions and methods
EP3030294B1 (en) 2013-08-05 2020-10-07 MannKind Corporation Insufflation apparatus
WO2015021044A1 (en) * 2013-08-05 2015-02-12 University Of Rochester Compositions and methods for stimuli-responsive release of a therapeutic agent
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
WO2015153996A1 (en) 2014-04-03 2015-10-08 Micro Vention, Inc. Embolic devices
WO2015167752A1 (en) 2014-04-29 2015-11-05 Microvention, Inc. Polymers including active agents
WO2015167751A1 (en) 2014-04-29 2015-11-05 Microvention, Inc. Polymers
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
US10265405B2 (en) 2014-11-18 2019-04-23 Board Of Regents, The University Of Texas System Polymers for delivery of factor VIII and/or factor IX
WO2016201250A1 (en) 2015-06-11 2016-12-15 Microvention, Inc. Expansile device for implantation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2976576A (en) * 1956-04-24 1961-03-28 Wichterle Otto Process for producing shaped articles from three-dimensional hydrophilic high polymers
US3220960A (en) * 1960-12-21 1965-11-30 Wichterle Otto Cross-linked hydrophilic polymers and articles made therefrom
IT1050353B (it) * 1966-01-06 1981-03-10 Ceskoslovenska Akademie Ved Supporti per sostanze biologigamente attive
US3607848A (en) * 1967-08-07 1971-09-21 Ceskoslovenska Akademie Ved Method for preparing insoluble,cross-linked organic hydrogels comprising copolymers of glycol monoesters with diesters
US3885078A (en) * 1968-03-06 1975-05-20 Ceskoslovenska Akademie Ved Hydrogel laminates and method of manufacturing thereof
US4071508A (en) * 1975-02-11 1978-01-31 Plastomedical Sciences, Inc. Anionic hydrogels based on hydroxyalkyl acrylates and methacrylates
FR2601026B1 (fr) * 1986-04-15 1988-09-16 Rhone Poulenc Chimie Matiere seche hydratable en un gel aqueux contenant des particules de polymeres dispersees, procede pour sa preparation et son application en biologie

Also Published As

Publication number Publication date
IL132176A0 (en) 2001-03-19
CN1259045A (zh) 2000-07-05
YU49699A (sh) 2002-12-10
PL335974A1 (en) 2000-06-05
EP0975328A1 (en) 2000-02-02
WO1998043615A1 (en) 1998-10-08
JP2002512607A (ja) 2002-04-23
AU727053B2 (en) 2000-11-30
AU6880998A (en) 1998-10-22
NO994757L (no) 1999-11-29
NO994757D0 (no) 1999-09-30
NZ500075A (en) 2001-03-30
KR20010005952A (ko) 2001-01-15
BR9808466A (pt) 2001-08-07
TR199903240T2 (xx) 2000-05-22

Similar Documents

Publication Publication Date Title
AU727053B2 (en) Method for oral delivery of proteins
Lowman et al. Oral delivery of insulin using pH‐responsive complexation gels
Foss et al. Development of acrylic-based copolymers for oral insulin delivery
Morishita et al. Elucidation of the mechanism of incorporation of insulin in controlled release systems based on complexation polymers
Nakamura et al. Oral insulin delivery using P (MAA-g-EG) hydrogels: effects of network morphology on insulin delivery characteristics
Jiménez-castellanos et al. Mucoadhesive drug delivery systems
Morishita et al. Mucosal insulin delivery systems based on complexation polymer hydrogels: effect of particle size on insulin enteral absorption
Kim et al. Polymeric drug delivery systems
EP0245820B1 (en) Biodegradable microspheres as a carrier for macromolecules
US5160745A (en) Biodegradable microspheres as a carrier for macromolecules
Peppas et al. Hydrogels for oral delivery of therapeutic proteins
Kamei et al. Complexation hydrogels for intestinal delivery of interferon β and calcitonin
Ramkissoon-Ganorkar et al. Modulating insulin-release profile from pH/thermosensitive polymeric beads through polymer molecular weight
EP0434438B1 (en) Hydrolytically degradable hydrophilic gels and the method for preparation thereof
Kumar et al. Development of PEGDMA: MAA based hydrogel microparticles for oral insulin delivery
CA2018471A1 (en) Mucoadhesive hydrogels delivery system
WO1995003035A1 (en) Polymerized liposomes with enhanced stability for oral delivery
WO1998022097A2 (en) Controlled release matrix composition using polar polymer or monomer and poly(acrylic acid) blend
Goto et al. Gastrointestinal transit and mucoadhesive characteristics of complexation hydrogels in rats
WO2008055254A2 (en) Formulations and methods for oral delivery of proteins
Smart Some formulation factors influencing the rate of drug release from bioadhesiw matrices
AU2002256333B2 (en) A release pharmaceutical construct for gastric retention
CZ349499A3 (cs) Farmaceutický přípravek určený pro orální podávání, způsob jeho použití a výroby
Kumar et al. EUDRAGIT POLYMERS IN COLON TARGETED ORAL DELIVERY OF INSULIN.
Gwon et al. New route for synthesizing poly (ethylene glycol)-acrylic acid hydrogels using γ-irradiation for drug delivery carriers

Legal Events

Date Code Title Description
FZDE Discontinued